GSK Biologicals

General presentation

GlaxoSmithKline is one of the world?s leading research-based pharmaceutical and healthcare companies. GlaxoSmithKline is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information, visit www.gsk.com. GSK Biologicals, the vaccine division of GlaxoSmithKline, is one of the world's leading vaccine manufacturers. GSK Biologicals is headquartered in Rixensart, Belgium, where the majority of GlaxoSmithKline's activities in the field of vaccine research, development and production are conducted. GSK Biologicals employs more than 1,500 scientists, who are devoted to discovering new vaccines and developing more cost-effective and convenient combination products to prevent infections that cause serious medical problems worldwide. GSK Biologicals is also developing innovative immunotherapy compounds to treat cancer patients. In 2005, GSK Biologicals distributed more than 1.2 billion doses of vaccines to 165 countries in both the developed and developing world, an average of three million doses a day. In the next five years, GSK Biologicals expects to launch five major new vaccines: an HPV vaccine targeting cervical cancer, a vaccine against rotavirus-induced gastroenteritis (now licensed in 41 countries in addition to the European Union markets), a vaccine to prevent pneumococcal disease, an improved flu vaccine for the elderly, and several meningitis combination vaccines.

Products / Services

Dvelopement

Domains of specialization

• Pharmaceutical Company